当前位置: 首页 >> 检索结果
共有 4182 条符合本次的查询结果, 用时 4.3494067 秒

121. Intermittent Asthma and Risk of Severe Exacerbation in Children.

作者: Shahid Sheikh.;Mariah Eisner.;Kelin Wheaton.;Joshua Kilbarger.;Lisa Ulrich.;Sabrina Palacios.;Karen S McCoy.
来源: Chest. 2025年
Because of risk of severe asthma exacerbations, current Global Initiative for Asthma recommendations advise against use of short-acting beta-agonists (SABAs) alone as the first step in treating mild asthma. It is unclear if everyone with mild asthma carries equal risk for severe asthma exacerbations.

122. Procedure Patterns and Survival in Advanced Non-Small Cell Lung Cancer with Malignant Airway Obstruction: A Surveillance, Epidemiology, and End Results Medicare Analysis.

作者: Septimiu D Murgu.;Meijia Zhou.;Balaji Laxmanan.;Charlene A Wong.;Tony B Amos.;Iftekhar Kalsekar.;Anil Vachani.
来源: Chest. 2025年
Malignant airway obstruction (MAO) is a common debilitating complication in advanced lung cancer. Therapeutic bronchoscopy is successfully applied to manage MAO. MAO recurs and requires repeat procedures.

123. Inflammatory and Mucociliary Dysfunction-Based Endotypes Across the Spectrum of Chronic Airway Diseases.

作者: Erin Cant.;Mathieu Bottier.;Morven Shuttleworth.;Jamie Stobo.;Lidia Perea.;Simon Finch.;Merete Long.;Hollian Richarson.;Daniela Alferes de Lima Headley.;Jeffrey T J Huang.;Amelia Shoemark.;James D Chalmers.
来源: Chest. 2025年
There is substantial overlap between features of COPD, asthma, bronchiectasis (BE), and cystic fibrosis (CF). Each is characterized by inflammation and mucociliary dysfunction.

124. Failure to Report Sex-Specific Risk Factors in Heart Failure With Preserved Ejection Fraction Research: A Scoping Review.

作者: Kathryn A Drury.;Josie A Seeto.;Serena Hong.;Michael A Wewege.;Amanda D Hagstrom.
来源: Chest. 2025年
Despite research identifying clear sex-specific differences in the risk profile for heart failure with preserved ejection fraction (HFpEF), these risk factors are typically not reported in "participant characteristics" of heart failure research. This leads to an incomplete understanding of how and why females are heavily predisposed to developing HFpEF.

125. Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension.

作者: Bettia Celestin.;Shadi P Bagherzadeh.;Everton Santana.;Matthew Frost.;Mathias Iversen.;Frida N Hermansson.;Andrew Sweatt.;Roham T Zamanian.;Yoran M Hummel.;Gabriela Gomez Rendon.;Joseph Yen.;Marinella Sandros.;Michael Salerno.;Francois Haddad.
来源: Chest. 2025年
Echocardiography is central when assessing pulmonary hypertension (PH), but manual interpretation can be time-consuming and prone to error.

126. Sotatercept and the Development of Pericardial Effusions: An Emerging Safety Signal.

作者: Jared Larson.;Michael J Cuttica.;Ruben Mylvaganam.
来源: Chest. 2025年

127. Association of Hypoxic Burden With Cardiovascular Events: A Risk Stratification Analysis of the Randomized Intervention With CPAP in Coronary Artery Disease and Sleep Apnea Cohort.

作者: Yüksel Peker.;Yeliz Celik.;Andrey Zinchuk.;Scott A Sands.;Susan Redline.;Ali Azarbarzin.
来源: Chest. 2025年
The apnea-hypopnea index (AHI), the standard measure of OSA, has limitations in reflecting disease severity.

128. Contemporary Trends in Pediatric Extubation Failure and Noninvasive Respiratory Support Use.

作者: Jeremy M Loberger.;Mitchell Moore.;Matthew Scanlon.;Robinder G Khemani.;Samer Abu-Sultaneh.;Colin M Rogerson.
来源: Chest. 2025年
Prolonged invasive mechanical ventilation (IMV) is associated with morbidity and mortality in children. Timely extubation is essential and must balance the competing risks of extubation failure (EF) and prolonged use of noninvasive respiratory support after extubation.

129. Geographical Distribution of Phase II/III Pharmaceutical Randomized Controlled Trials in Adults With Interstitial Lung Disease.

作者: Mingkun Guan.;Emma Marshall.;Sadhana Sughesh.;Hong Ye.;Christopher J Ryerson.;Yet H Khor.
来源: Chest. 2025年
Pharmaceutical randomized controlled trials (RCTs) are critical for advancing treatments in interstitial lung disease (ILD). This study evaluated global distribution of pharmaceutical RCTs of ILD and their associations with country-specific features.

130. Association Between Hospital Safety-Net Status and Delivery of Rehabilitation to Older Adults With Acute Respiratory Failure.

作者: Jose Victor Jimenez.;Lingxiao Zhang.;Zhenqiu Lin.;Lauren E Ferrante.;Jason R Falvey.;Allan J Walkey.;Harlan M Krumholz.;Snigdha Jain.
来源: Chest. 2025年
Older adults with socioeconomic disadvantage experience greater decline in function and cognition after critical illness, an adverse outcome potentially preventable through mobilization. Whether safety-net hospitals (SNHs) that serve the highest proportions of patients with socioeconomic disadvantage are less likely to deliver rehabilitation during hospitalization with stay in the ICU is unknown.

131. Mortality Outcomes and ACE Inhibitor Use in Patients With Idiopathic Pulmonary Fibrosis.

作者: Burcu Ozaltin.;Robert Chapman.;Tine Follet.;Marie Vermant.;Muhammad Qummer Ul Arfeen.;Natalie Fitzpatick.;Harry Hemingway.;Wim Wuyts.;Kenan Direk.;Joseph Jacob.
来源: Chest. 2025年
Angiotensin-converting enzyme (ACE) inhibitors are widely used antihypertensive agents with proven cardioprotective effects. Previous mechanistic and clinical studies have suggested that ACE inhibitor therapy may slow disease progression and reduce mortality in idiopathic pulmonary fibrosis (IPF).

132. Response.

作者: Sara E Golden.;Christopher G Slatore.
来源: Chest. 2025年168卷2期e56-e57页

133. Reassessing Communication Strategies in Lung Cancer Screening: Implications for Patient-Centered Outcomes.

作者: Yingjian Ye.;Peng An.
来源: Chest. 2025年168卷2期e55-e56页

134. Thoughts and Insights on Changes in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary Fibrosis.

作者: Lu-Ting Shen.;Hong-Lin Chen.
来源: Chest. 2025年168卷2期e54-e55页

135. Considerations for the Use of CO2-O2-Derived Indices in Shock Resuscitation.

作者: Daisuke Kawakami.;Takahisa Niimoto.
来源: Chest. 2025年168卷2期e53-e54页

136. Facility-Level Factors as a Potential Confounder in Studies on Paco2 Targets in Venoarterial Extracorporeal Membrane Oxygenation Management.

作者: Shohei Ono.
来源: Chest. 2025年168卷2期e51页

137. Response.

作者: Junichi Izawa.;Sho Komukai.;Masashi Okubo.
来源: Chest. 2025年168卷2期e51-e53页

138. Quo Vadis Ventilatory (In)Efficiency in Respiratory Physiology?

作者: Paulo de Tarso Müller.
来源: Chest. 2025年168卷2期e49页

139. Response.

作者: Magnus Ekström.;Pei Zhi Li.;Hayley Lewthwaite.;Jean Bourbeau.;Wan C Tan.;Dennis Jensen.
来源: Chest. 2025年168卷2期e49-e50页

140. Response.

作者: Michele R Schaeffer.;Lucas Vanden Bossche.;Kaat Beckers.;Kristin Verbeke.;Wim Janssens.;Dennis Jensen.;Jem I Arnold.;Andreas von Leupoldt.;Daniel Langer.
来源: Chest. 2025年168卷2期e47-e49页
共有 4182 条符合本次的查询结果, 用时 4.3494067 秒